Risk of epilepsy in type 1 diabetes mellitus: a population-based cohort study

Diabetologia

Volumn 59, Issue 6, 2016, Pages 1196-1203

  Chou, I Ching ^a,b   Wang, Chung Hsing ^a,c   Lin, Wei De ^b,d   Tsai, Fuu Jen ^a,b,d,e   Lin, Che Chen ^c,d   Kao, Chia Hung ^c,d  

^a CHINA MEDICAL UNIVERSITY CHILDREN S HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

Author keywords

Epilepsy; National Health Insurance Research Database; Type 1 diabetes

Indexed keywords

ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHILD; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GROUPS BY AGE; HEAD INJURY; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTELLECTUAL IMPAIRMENT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; TAIWAN; URBANIZATION; ADOLESCENT; COMPLICATION; DIABETES MELLITUS, TYPE 1; EPILEPSY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADOLESCENT; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; EPILEPSY; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84962299004     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-3929-0     Document Type: Article

References (37)

1. Knip M, Siljander H (2008) Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 7:550–557
2. Rawshani A, Landin-Olsson M, Svensson AM et al (2014) The incidence of diabetes among 0–34 year olds in Sweden: new data and better methods. Diabetologia 57:1375–1381
3. Patterson C, Guariguata L, Dahlquist G, Soltész G, Ogle G, Silink M (2014) Diabetes in the young—a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract 103:161–175
4. Atkinson MA, Eisenbarth GS, Michels AW (2014) Type 1 diabetes. Lancet 383:69–82
5. Kollipara S (2006) Comorbidities associated with type 1 diabetes. School Nurse News 23:42–45
6. Zhao Y, Ye W, Boye KS, Holcombe JH, Swindle R (2009) Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities. Diabet Med 26:61–69
7. Moshè SL, Perucca E, Ryvlin P, Tomson T (2015) Epilepsy: new advances. Lancet 7:884–898
8. Fisher RS, Acevedo C, Arzimanoglou A et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475–482
9. Cowan LD (2002) The epidemiology of the epilepsies in children. Ment Retard Dev Disabil Res Rev 8:171–181
10. Soltész G, Acsádi G (1989) Association between diabetes, severe hypo-glycaemia, and electroencephalographic abnormalities. Arch Dis Child 64:992–996
11. Bergey GK (2012) Autoantibodies in the patient with drug-resistant epilepsy: are we missing a treatable etiology? Arch Neurol 69:565–566
12. Palace J, Lang B (2000) Epilepsy: an autoimmune disease? J Neurol Neurosurg Psychiatry 69:711–714
13. McKnight K, Jiang Y, Hart Y et al (2005) Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65:1730–1736
14. Barajas RF, Collins DE, Cha S, Geschwind MD (2010) Adult-onset drug-refractory seizure disorder associated with anti-voltage–gated potassium-channel antibody. Epilepsia 51:473–477
15. Liimatainen S, Peltola M, Sabater L et al (2010) Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 51:760–767
16. Lin JJ, Lin KL, Hsia SH, Wang HS, Chou IJ, Lin YT (2012) CHEESE Study Group. Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus. Pediatr Neurol 47:252–258
17. Dalmau J, Gleichman AJ, Hughes EG et al (2008) Anti–NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098
18. McCorry D, Nicolson A, Smith D, Marson A, Feltbower RG, Chadwick DW (2006) An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol 59:204–206
19. O’Connell MA, Harvey AS, Mackay MT, Cameron FJ (2008) Does epilepsy occur more frequently in children with Type 1 diabetes? J Paediatr Child Health 44:586–589
20. Silverstein J, Klingensmith G, Copeland K et al (2005) Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 28:186
21. American Diabetes Association (2011) Standards of medical care in diabetes. Diabetes Care 34(Suppl 1):S11
22. Liu CY, Hung YT, Chuang YL et al (2006) Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag 14:1–22
23. Yun C, Xuefeng W (2013) Association between seizures and diabetes mellitus: a comprehensive review of literature. Curr Diabetes Rev 9:350–354
24. Maheandiran M, Mylvaganam S, Wu C et al (2013) Severe hypoglycemia in a juvenile diabetic rat model: presence and severity of seizures are associated with mortality. PLoS One 8:e83168
25. Schwechter EM, Velísková J, Velísek L (2003) Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann Neurol 53:91–101
26. Kirchner A, Velísková J, Velísek L (2006) Differential effects of low glucose concentrations on seizures and epileptiform activity in vivo and in vitro. Eur J Neurosci 23:1512–1522
27. Ong MS, Kohane IS, Cai T, Gorman MP, Mandl KD (2014) Population-level evidence for an autoimmune etiology of epilepsy. JAMA Neurol 71:569–574
28. Striano P, Errichiello L, Striano S (2011) Autoantibodies to glutamic acid decarboxylase in patients with epilepsy: what is their clinical relevance? Epilepsy Behav 20:145
29. Saiz A, Blanco Y, Sabater L et al (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131:2553–2563
30. Olson JA, Olson DM, Sandborg C, Alexander S, Buckingham B (2002) Type 1 diabetes mellitus and epilepsy partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies. Pediatrics 109, E50
31. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28:726–735
32. Desrocher M, Rovet J (2004) Neurocognitive correlates of type 1 diabetes mellitus in childhood. Child Neuropsychol 10:36–52
33. Northam EA, Rankins D, Cameron FJ (2006) Therapy insight: the impact of type 1 diabetes on brain development and function. Nat Clin Pract Neurol 2:78–86
34. Knight S, Northam E, Donath S et al (2009) Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with type 1 diabetes mellitus: a pilot study. Diabetologia 52:193–198
35. Wayne EA, Dean HJ, Booth F, Tenenbein M (1990) Focal neurological deficits associated with hypoglycemia in children with diabetes. J Pediatr 117:575–577
36. Lahat E, Barr J, Bistritzer T (1995) Focal epileptic episodes associated with hypoglycemia in children with diabetes. Clin Neurol Neurosurg 97:314–316
37. Home P, Haddad J, Latif ZA et al (2013) Comparison of national/regional diabetes guidelines for the management of blood glucose control in non-Western Countries. Diabetes Ther 4:91–102